Article Sidebar
Published:
Aug 17, 2020Keywords:
Angioid streak; choroidal neovascular membrane; comet-tail lesion; ranibizumab; aflibercept
Article Details
Issue
Section
Articles
Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Main Article Content
Clinical characteristics and treatment outcomes of angioid streak associated choroidal neovascular membrane (AS-CNV): a Zambian case series
Abstract
This case series illustrates clinical features and
treatment outcomes of angioid streak associated
CNV (AS-CNV) in 3 consecutive patients. Mean age
of patients was 43.2 years with one female
patient. Bilateral CNV was present in one patient.
Comet-tail lesions were present in all cases. No
underlying systemic association was found in any
of the patients. All patients were treated with 3
loading doses of anti-VEGF injections (ranibizumab
in two and aflibercept was used in one case).
Subretinal fluid resolved in all cases with no
recurrence of CNV activity at mean follow-up of
10.75 months. AS-CNV in Zambian eyes responds
favourably to anti-VEGF injections.
